- Home
- / Kolinpharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kolinpharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
€14.1 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 7.2M | 8.9M | 8.2M | 11.2M | 14.1M |
| Cost of goods sold | 6.0M | 5.3M | 4.8M | 2.8M | 3.8M |
| Gross profit | 1.3M | 3.7M | 3.6M | 8.7M | 10.6M |
| Gross profit margin, % | 18.3% | 41.9% | 44.4% | 77.5% | 75.1% |
| Operating expense total | (71.0K) | 1.7M | 1.7M | 6.5M | 8.3M |
| Depreciation and amortization | 833.0K | 963.0K | 906.0K | 978.0K | 1.4M |
| EBITDA | 1.4M | 2.0M | 1.9M | 2.1M | 2.2M |
| EBITDA margin, % | 19.3% | 22.2% | 23.2% | 19.1% | 15.8% |
| EBIT | 548.0K | 1.0M | 994.0K | 1.2M | 830.0K |
| EBIT margin, % | 7.6% | 11.4% | 12.1% | 10.3% | 5.9% |
| Interest expense | 87.0K | 71.0K | 107.0K | 239.0K | 241.0K |
| Pre tax profit | 461.0K | 795.0K | 886.0K | 917.0K | 595.0K |
| Income tax expense | 186.0K | 204.0K | 243.0K | 281.0K | 253.0K |
| Net Income | 275.0K | 591.0K | 643.0K | 636.0K | 342.0K |